Background Although CT, endoscopic US, and PET are critical in determining the
appropriate management of esophageal carcinoma (squamous cell carcinoma and …

Simple Summary Esophageal cancer (EC) is the eighth most frequent cancer worldwide,
with a poor prognosis. Current imaging modalities for staging and follow-up mainly include …

Background Patients with esophageal cancer (EC) undergo endoscopic ultrasound and CT
based cancer staging. Recent technical developments allow improved MRI quality with …

Objectives To outline the current role and future potential of magnetic resonance imaging
(MRI) in the management of oesophageal cancer regarding T-staging, N-staging, tumour …

Over the past few decades, the survival of esophageal cancer patients has improved owing
to early detection and advances in multimodality treatment strategies. Imaging plays an …

Esophageal cancer is a relatively uncommon malignancy in the United States, although its
incidence has been increasing since the 1980s. It currently ranks seventh in terms of …

OBJECTIVE. The purpose of this study was to explore the value of 3-T MRI for evaluating the
preoperative T staging of esophageal cancer (EC) treated with neoadjuvant chemotherapy …

Background Clinical staging of esophageal cancer has improved with positron-emission
tomography/computed tomography and endoscopic ultrasound imaging. Despite such …

Fluorodeoxyglucose-positron emission tomography (FDG-PET) and computed tomography
(CT) have become the gold standard for staging of esophageal cancer by detecting distant …

Esophageal cancer is a leading cause of cancer-related deaths worldwide, and the 5-year
relative survival rate remains less than 20% in the United States. The treatment of …